Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 63 citing articles:

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
Mary E. Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui, et al.
Hepatology (2023) Vol. 77, Iss. 5, pp. 1797-1835
Open Access | Times Cited: 1137
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
Kenneth Cusi, Scott Isaacs, Diana Barb, et al.
Endocrine Practice (2022) Vol. 28, Iss. 5, pp. 528-562
Open Access | Times Cited: 642
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
Norbert Stefan, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 4, pp. 284-296
Closed Access | Times Cited: 397
Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
Fasiha Kanwal, Jay H. Shubrook, Leon A. Adams, et al.
Gastroenterology (2021) Vol. 161, Iss. 5, pp. 1657-1669
Open Access | Times Cited: 372
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
Romina Lomonaco, Eddison Godinez Leiva, Fernando Bril, et al.
Diabetes Care (2020) Vol. 44, Iss. 2, pp. 399-406
Open Access | Times Cited: 246
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis
Elina Cho, C. Ang, Jingxuan Quek, et al.
Gut (2023) Vol. 72, Iss. 11, pp. 2138-2148
Closed Access | Times Cited: 115
Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis
Federico Ravaioli, Elton Dajti, Alessandro Mantovani, et al.
Gut (2023) Vol. 72, Iss. 7, pp. 1399-1409
Closed Access | Times Cited: 50
Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study
Michelle T. Long, Xiaoyu Zhang, Hanfei Xu, et al.
Hepatology (2020) Vol. 73, Iss. 2, pp. 548-559
Open Access | Times Cited: 80
Non‐alcoholic fatty liver disease and type 2 diabetes: An update
Chi‐Ho Lee, David Tak Wai Lui, Karen SL Lam
Journal of Diabetes Investigation (2022) Vol. 13, Iss. 6, pp. 930-940
Open Access | Times Cited: 66
Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?
Moein Ala, Mahan Ala
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 6, pp. 1747-1770
Open Access | Times Cited: 63
Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis
Stefano Ciardullo, Cinzia Ballabeni, Roberto Trevisan, et al.
Biomolecules (2022) Vol. 12, Iss. 1, pp. 105-105
Open Access | Times Cited: 38
Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality
Stefano Ballestri, Alessandro Mantovani, Maria Di Girolamo, et al.
Metabolism and Target Organ Damage (2023) Vol. 3, Iss. 1, pp. 1-1
Open Access | Times Cited: 27
Surveillance of the liver in type 2 diabetes: important but unfeasible?
S. U. Qadri, Hannele Yki‐Järvinen
Diabetologia (2024) Vol. 67, Iss. 6, pp. 961-973
Open Access | Times Cited: 13
MAFLD and CKD: An Updated Narrative Review
Alessandro Mantovani, Rosa Lombardi, Filippo Cattazzo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7007-7007
Open Access | Times Cited: 34
Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: A systematic review and meta-analysis
Stefano Ciardullo, Gianluca Perseghin
Diabetes Research and Clinical Practice (2022) Vol. 190, pp. 109981-109981
Closed Access | Times Cited: 34
Screening for Liver Fibrosis in the General Population: Where Do We Stand in 2022?
Clémence M. Canivet, Jérôme Boursier
Diagnostics (2022) Vol. 13, Iss. 1, pp. 91-91
Open Access | Times Cited: 25
Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis
Andrea Dalbeni, Rosa Lombardi, M. K. Costa Luís Henrique, et al.
Hepatology (2023) Vol. 79, Iss. 5, pp. 1107-1116
Closed Access | Times Cited: 13
Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease
Alessandro Mantovani, G. Lunardi, Stefano Bonapace, et al.
Diabetes & Metabolism (2020) Vol. 47, Iss. 1, pp. 101152-101152
Open Access | Times Cited: 33
Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease
Margaux Nawrot, Simon Peschard, Sophie Lestavel, et al.
Metabolism (2021) Vol. 123, pp. 154844-154844
Open Access | Times Cited: 29
Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis
Jianghua Zhou, Dan‐Qin Sun, Giovanni Targher, et al.
eGastroenterology (2023) Vol. 1, Iss. 1, pp. e100005-e100005
Open Access | Times Cited: 12
An insight on the additive impact of type 2 diabetes mellitus and nonalcoholic fatty liver disease on cardiovascular consequences
Monika Bhardwaj, Papiya Mitra Mazumder
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Metabolic dysfunction‐associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi‐centre cross‐sectional study
Michela Vergani, Nicolò Diego Borella, Maria Rosaria Rizzo, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
ANTI-OBESITY MEDICATIONS IN ADULT AND PEDIATRIC OBESITY AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Natalie Rodríguez, Phillipp Hartmann
Pharmacological Reviews (2025), pp. 100058-100058
Open Access
Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population
Lars Lind, L. E. B. Johansson, Håkan Åhlström, et al.
World Journal of Hepatology (2020) Vol. 12, Iss. 4, pp. 149-159
Open Access | Times Cited: 31
The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Shelley Harris, Toryn Poolman, Anastasia Arvaniti, et al.
AJP Gastrointestinal and Liver Physiology (2020) Vol. 319, Iss. 3, pp. G345-G360
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top